These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11886488)

  • 1. Systemic granulomatosis and hypercalcaemia following intravesical bacillus Calmette-Guérin immunotherapy.
    Schattner A; Gilad A; Cohen J
    J Intern Med; 2002 Mar; 251(3):272-7. PubMed ID: 11886488
    [No Abstract]   [Full Text] [Related]  

  • 2. Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy.
    Ozbakkaloglu B; Tünger O; Sürücüoglu S; Lekili M; Kandiloglu AR
    Int Urol Nephrol; 1999; 31(1):49-53. PubMed ID: 10408303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of granulomatous hepatitis after intravesical bacillus Calmette-Guerin administration.
    Graziano DA; Jacobs D; Lozano RG; Buck RL
    J Urol; 1991 Oct; 146(4):1118-9. PubMed ID: 1895437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy for bladder carcinoma.
    Marans HY; Bekirov HM
    J Urol; 1987 Jan; 137(1):111-2. PubMed ID: 3795348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent acid-fast bacilli following intravesical bacillus Calmette-Guerin.
    Linn R; Klimberg IW; Wajsman Z
    J Urol; 1989 May; 141(5):1197-8. PubMed ID: 2709508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma.
    Proctor DD; Chopra S; Rubenstein SC; Jokela JA; Uhl L
    Am J Gastroenterol; 1993 Jul; 88(7):1112-5. PubMed ID: 8317415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculous epididymitis following intravesical Bacillus Calmette-Guérin immunotherapy.
    Hoag N; Pommerville PJ; Kibsey PC; Cavers DJ; Eddy RJ
    Can J Urol; 2009 Apr; 16(2):4589-91. PubMed ID: 19364433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitiligo--an autoimmune side-effect of intravesical bacillus Calmette-Guérin instillation?
    Beisland C; Holsen DS
    Scand J Urol Nephrol; 2004; 38(2):182-3. PubMed ID: 15204415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: renal granuloma following intra-vesical bacillus Calmette-Guerin.
    Goh PY; Htoo MM; Yeong KY
    Clin Radiol; 1996 Jan; 51(1):69-72. PubMed ID: 8549054
    [No Abstract]   [Full Text] [Related]  

  • 10. [Calmette-Guerin bacillus disseminated infection after intravesical instillation].
    Borré S; Brustia D; Rosa F; Brondolo R; Rizzo G; Garavelli PL
    Recenti Prog Med; 2002 Apr; 93(4):247-8. PubMed ID: 11989131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal disseminated mycobacterial infection following intravesical bacillus Calmette-Guerin.
    Deresiewicz RL; Stone RM; Aster JC
    J Urol; 1990 Dec; 144(6):1331-3; discussion 1333-4. PubMed ID: 2231918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder and penile lesions with inguinal adenopathy after intravesical Bacillus Calmette-Guerin (BCG) treatment.
    Yates J; Stein B
    Urology; 2007 Dec; 70(6):1223.e15-7. PubMed ID: 18158061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Guérin.
    Soylu A; Ince AT; Polat H; Yasar N; Ciltas A; Ozkara S; Tasci AI
    Ann Clin Microbiol Antimicrob; 2009 Apr; 8():12. PubMed ID: 19368735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic bacillus-Calmette Guerin infection after transurethral administration for superficial bladder carcinoma.
    Sakamoto GD; Burden J; Fisher D
    J Urol; 1989 Oct; 142(4):1073-4; discussion 1074-5. PubMed ID: 2795734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular involvement following Bacillus Calmette-Guerin immunotherapy for bladder carcinoma.
    Cugati S; Gilhotra JS; Lake S; Gordon DL
    Clin Exp Ophthalmol; 2014 Jul; 42(5):494-5. PubMed ID: 24372891
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypersensitivity systemic reaction following intravesical bacillus Calmette-Guerin: successful treatment with steroids.
    Molina JM; Rabian C; D'Agay MF; Modai J
    J Urol; 1992 Mar; 147(3):695-7. PubMed ID: 1538462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal complications of intravesical bacillus Calmette-Guérin therapy.
    Modesto A; Marty L; Suc JM; Kleinknecht D; de Frémont JF; Marsepoil T; Veyssier P
    Am J Nephrol; 1991; 11(6):501-4. PubMed ID: 1819218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCG pyelonephritis following intravesical therapy for transitional cell carcinoma.
    Garcia JE; Thiel DD; Broderick GA
    Can J Urol; 2007 Apr; 14(2):3523-5. PubMed ID: 17466161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium bovis infection of an implantable defibrillator following intravesical therapy with bacille Calmette-Guérin.
    Stone DR; Estes NA; Klempner MS
    Clin Infect Dis; 1993 Jun; 16(6):825-6. PubMed ID: 8329515
    [No Abstract]   [Full Text] [Related]  

  • 20. [Endovesical immunotherapy: Calmette-Guérin bacillus].
    Chopin D; Saint F; Gattegno B
    Prog Urol; 2001 Nov; 11(5):1067-115. PubMed ID: 11769075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.